Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Birmingham, Alabama 35294


Purpose:

The study will evaluate the effects of the direct renin inhibitor, aliskiren, on flow-mediated dilation of the brachial artery and on central aortic pressure in diabetic patients with pre-hypertension or Stage 1 hypertension.


Criteria:

Inclusion Criteria: - Type 2 diabetes - prehypertension or Stage 1 hypertension Exclusion Criteria: - Type 1 diabetes - Stage 2 hypertension - CKD - recent MI, revascularization, CVA or TIA


NCT ID:

NCT01349114


Primary Contact:

Principal Investigator
David A Calhoun, MD
University of Alabama at Birmingham

David Calhoun, MD
Phone: 205-934-4633
Email: dcalhoun@uab.edu


Backup Contact:

N/A


Location Contact:

Birmingham, Alabama 35294
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.